PSNL stock forecast
Our latest prediction for Personalis Inc's stock price was made on the Feb. 1, 2024 when the stock price was at 1.29$.
In the short term (2weeks), PSNL's stock price should underperform the market by -1.22%. During that period the price should oscillate between -10.04% and +7.92%.
In the medium term (3months), PSNL's stock price should underperform the market by -4.30%. During that period the price should oscillate between -32.52% and +14.71%.
Get email alertsCreate a solid portfolio with PSNL
About Personalis Inc
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.29$ per share.
The book value per share is 3.13$
Three months stock forecastFeb. 1, 2024
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -118M | - | -112M | -2.29 | - | - | 49M | 3.13 | - | - | - |